Magnetic nanoparticles in cancer therapy and diagnosis

A Farzin, SA Etesami, J Quint, A Memic… - Advanced healthcare …, 2020 - Wiley Online Library
There is urgency for the development of nanomaterials that can meet emerging biomedical
needs. Magnetic nanoparticles (MNPs) offer high magnetic moments and surface‐area‐to …

Interactions between tumor biology and targeted nanoplatforms for imaging applications

M Azizi, H Dianat‐Moghadam, R Salehi… - Advanced functional …, 2020 - Wiley Online Library
Although considerable efforts have been conducted to diagnose, improve, and treat cancer
in the past few decades, existing therapeutic options are insufficient, as mortality and …

Toxicity of iron oxide nanoparticles: Size and coating effects

MA Abakumov, AS Semkina… - … of biochemical and …, 2018 - Wiley Online Library
Toxicological research of novel nanomaterials is a major developmental step of their clinical
approval. Since iron oxide magnetic nanoparticles have a great potential in cancer treatment …

Development of magneto-plasmonic nanoparticles for multimodal image-guided therapy to the brain

A Tomitaka, H Arami, A Raymond, A Yndart, A Kaushik… - Nanoscale, 2017 - pubs.rsc.org
Magneto-plasmonic nanoparticles are one of the emerging multi-functional materials in the
field of nanomedicine. Their potential for targeting and multi-modal imaging is highly …

Stealth cross-linked polymeric nanoparticles for passive drug targeting: a combination of molecular docking and comprehensive in vitro assay

A HEMATI AZANDARYANI, S Kashanian… - Bulletin of Materials …, 2020 - Springer
Till date, several studies have reported magnetic drug targeting as well as passive drug
delivery. In this study, the passive characteristic of PEGylated carriers with a neutral surface …

Stimuli-responsive magneto-plasmonic nanocarrier

A Tomitaka, N Madhavan - US Patent 10,561,745, 2020 - Google Patents
A61K 49/18(2006.01) A61K 49/00(2006.01) A61K 41/00(2006.01) A61K 47/69(2017.01)
A61K 49/04(2006.01) A61K 9/127(2006.01) A61K 9/00(2006.01)(52) US CI. CPC A61K …